يعرض 1 - 10 نتائج من 23 نتيجة بحث عن '"Lucie Nekvindová"', وقت الاستعلام: 1.67s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry

    المؤلفون: Lucie Nekvindová, Jiří Vencovský, Karel Pavelka, Pavel Horák, Zlatuše Křístková, Jakub Závada

    المصدر: Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)

    مصطلحات موضوعية: Registry, Treat-to-target, Rheumatoid arthritis, Propensity score, Diseases of the musculoskeletal system, RC925-935

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1478-6362Test

    الوصول الحر: https://doaj.org/article/cdac019808f04a84af01b113280dc57eTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA

    المؤلفون: Tomas Milota, Jana Hurnakova, Karel Pavelka, Zlatuse Kristkova, Lucie Nekvindova, Rudolf Horvath

    المصدر: Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)

    مصطلحات موضوعية: Diseases of the musculoskeletal system, RC925-935

    العلاقة: https://doi.org/10.1177/1759720X221081649Test; https://doaj.org/toc/1759-7218Test; https://doaj.org/article/51fdc92e7cbb480c9fe02c0414d1184cTest

    الإتاحة: https://doi.org/10.1177/1759720X221081649Test
    https://doaj.org/article/51fdc92e7cbb480c9fe02c0414d1184cTest

    View record in BASE النص الكامل

    أضف إلى المفضلة
  3. 3
    The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry

    المؤلفون: Martina, Skácelová, Lucie, Nekvindová, Heřman, Mann, Jakub, Závada, Zlatuše, Křístková, Jiří, Vencovský, Karel, Pavelka, Pavel, Horák

    المصدر: Rheumatology International. 42:803-814

    مصطلحات موضوعية: Adult, Tumor Necrosis Factor-alpha, Immunology, Arthritis, Rheumatoid, Methotrexate, Treatment Outcome, Rheumatology, Antirheumatic Agents, Humans, Immunology and Allergy, Drug Therapy, Combination, Tumor Necrosis Factor Inhibitors, Registries, Czech Republic, Retrospective Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0772fbaf804a647a08652c8a1ccf2d0Test
    https://doi.org/10.1007/s00296-021-05072-2Test


    أضف إلى المفضلة
  4. 4
    Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

    المؤلفون: Johan Askling, Burkhard Möller, Matija Tomšič, Lennart T H Jacobsson, Jakub Zavada, Thorvardur Jon Love, Daniela Di Giuseppe, Adrian Ciurea, Manuel Pombo-Suarez, Maria José Santos, Bjorn Gudbjornsson, Pedro Avila-Ribeiro, Catalin Codreanu, Brigitte Michelsen, Michael John Nissen, Carlos Sánchez-Piedra, Lykke Midtbøll Ørnbjerg, Karen Minde Fagerli, Bente Glintborg, Žiga Rotar, Bénédicte Delcoigne, Gareth T. Jones, Ruxandra Ionescu, Servet Yolbas, Ulf Lindström, Lucie Nekvindová, Heikki Relas, Mikkel Østergaard, Nuh Atas, Florenzo Iannone, Kari K. Eklund

    المساهمون: HUS Inflammation Center, Department of Medicine, Reumatologian yksikkö, Repositório da Universidade de Lisboa

    المصدر: Annals of the Rheumatic Diseases
    Repositório Científico de Acesso Aberto de Portugal
    Repositório Científico de Acesso Aberto de Portugal (RCAAP)
    instacron:RCAAP
    Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097Test

    مصطلحات موضوعية: Male, Placebo-controlled study, Psoriatic, PLACEBO-CONTROLLED TRIAL, THERAPY, Etanercept, DOUBLE-BLIND, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, skin and connective tissue diseases, Remission Induction, Middle Aged, Tumour necrosis factor inhibitors, Treatment Outcome, arthritis, Antirheumatic Agents, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Psoriatic Arthritis, tumour necrosis factor inhibitors, General Biochemistry, Genetics and Molecular Biology, methotrexate, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Internal medicine, Adalimumab, Humans, 030203 arthritis & rheumatology, business.industry, Arthritis, Arthritis, Psoriatic, EFFICACY, medicine.disease, Infliximab, Discontinuation, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Tumor Necrosis Factor Inhibitors, psoriatic, business

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022e520d9e5e31bc0cc0baf6321a0476Test
    http://europepmc.org/articles/PMC8522446Test


    أضف إلى المفضلة
  5. 5
    Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registry

    المؤلفون: Lucie Nekvindová, Jiří Vencovský, Karel Pavelka, Pavel Horák, Renata Rouhová, Jakub Závada

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9b2d36703586b1a8a7bd196b6dc806e7Test
    https://doi.org/10.21203/rs.3.rs-1643221/v1Test


    أضف إلى المفضلة
  6. 6
    Real‐world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO‐CLLEAR Study by the Czech CLL Study Group

    المؤلفون: Hynek Poul, Šárka Pospíšilová, Eva Koriťáková, Jan Novák, Michael Doubek, Lukas Smolej, Lucie Nekvindová, Lucie Němcová, Martin Spacek, Jana Zuchnická, Daniel Lysák, Karla Plevová, Filip Vrbacký, Renata Urbanova, Tomas Papajik, Yvona Brychtová, Stanislava Mašlejová, David Starostka, Martin Brejcha, Martin Simkovic, Pavel Vodárek, Anna Panovská

    المصدر: Hematological Oncology. 38:509-516

    مصطلحات موضوعية: Bendamustine, Cancer Research, medicine.medical_specialty, Chronic lymphocytic leukemia, Neutropenia, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Obinutuzumab, hemic and lymphatic diseases, Internal medicine, medicine, Chlorambucil, business.industry, Hematology, General Medicine, medicine.disease, 3. Good health, Regimen, Oncology, chemistry, 030220 oncology & carcinogenesis, Rituximab, business, Untreated Chronic Lymphocytic Leukemia, 030215 immunology, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6abf2d9a9f182b5d196c02636cbac2e7Test
    https://doi.org/10.1002/hon.2744Test


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries

    المؤلفون: Brigitte Michelsen, Stylianos Georgiadis, Daniela Di Giuseppe, Anne G Loft, Michael J Nissen, Florenzo Iannone, Manuel Pombo-Suarez, Herman Mann, Ziga Rotar, Kari K Eklund, Tore K Kvien, Maria J Santos, Bjorn Gudbjornsson, Catalin Codreanu, Sema Yilmaz, Johan K Wallman, Cecilie H Brahe, Burkhard Möller, Ennio G Favalli, Carlos S('(a))nchez-Piedra, Lucie Nekvindova, Matija Tomsic, Nina Trokovic, Eirik K Kristianslund, Helena Santos, Thorvardur J Löve, Ruxandra Ionescu, Yavuz Pehlivan, Gareth T Jones, Irene van der Horst-Bruinsma, Lykke M (O)rnbjerg, Mikkel (O)stergaard, Merete L Hetland

    المساهمون: Michelsen, Brigitte, Georgiadis, Styliano, Di Giuseppe, Daniela, G Loft, Anne, J Nissen, Michael, Iannone, Florenzo, Pombo-Suarez, Manuel, Mann, Herman, Rotar, Ziga, K Eklund, Kari, K Kvien, Tore, J Santos, Maria, Gudbjornsson, Bjorn, Codreanu, Catalin, Yilmaz, Sema, K Wallman, Johan, H Brahe, Cecilie, Mã¶ller, Burkhard, G Favalli, Ennio, S('(a))nchez-Piedra, Carlo, Nekvindova, Lucie, Tomsic, Matija, Trokovic, Nina, K Kristianslund, Eirik, Santos, Helena, J Löve, Thorvardur, Ionescu, Ruxandra, Pehlivan, Yavuz, T Jones, Gareth, van der Horst-Bruinsma, Irene, M (O)rnbjerg, Lykke, (O)stergaard, Mikkel, L Hetland, Merete

    مصطلحات موضوعية: TNFi retention, axial spondyloarthriti, psoriatic arthriti, remission, response, time trends

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33460531; journal:ARTHRITIS CARE & RESEARCH; http://hdl.handle.net/11586/379942Test

    الإتاحة: https://doi.org/10.1002/acr.24560Test
    http://hdl.handle.net/11586/379942Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

    المؤلفون: Irene E. van der Horst-Bruinsma, Manuel Pombo-Suarez, Tore K Kvien, Helena Santos, Johan K. Wallman, Sema Yilmaz, Ruxandra Ionescu, Lucie Nekvindová, Nina Trokovic, Kari K. Eklund, Maria José Santos, Ennio Giulio Favalli, Bjorn Gudbjornsson, Stylianos Georgiadis, Gareth T. Jones, Yavuz Pehlivan, Merete Lund Hetland, Florenzo Iannone, Carlos Sánchez-Piedra, Catalin Codreanu, Eirik Kristianslund, Anne Gitte Loft, Daniela Di Giuseppe, Ziga Rotar, Matija Tomšič, Brigitte Michelsen, Mikkel Østergaard, Burkhard Möller, Lykke Midtbøll Ørnbjerg, Michael John Nissen, Cecilie Heegaard Brahe, Herman Mann, Thorvardur Jon Love

    المساهمون: University of Helsinki, Clinicum, Department of Medicine, HUS Inflammation Center, Helsinki University Hospital Area

    المصدر: Michelsen, B, Georgiadis, S, Di Giuseppe, D, Loft, A G, Nissen, M J, Iannone, F, Pombo-Suarez, M, Mann, H, Rotar, Z, Eklund, K K, Kvien, T K, Santos, M J, Gudbjornsson, B, Codreanu, C, Yilmaz, S, Wallman, J K, Brahe, C H, Möller, B, Favalli, E G, Sánchez-Piedra, C, Nekvindova, L, Tomsic, M, Trokovic, N, Kristianslund, E K, Santos, H, Löve, T J, Ionescu, R, Pehlivan, Y, Jones, G T, van der Horst-Bruinsma, I, Ørnbjerg, L M, Østergaard, M & Hetland, M L 2022, ' Real-World Six-and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries ', Arthritis Care and Research, vol. 74, no. 7, pp. 1205-1218 . https://doi.org/10.1002/acr.24560Test
    Arthritis Care & Research, 74, 7, pp. 1205-1218
    Arthritis Care & Research, 74, 1205-1218

    مصطلحات موضوعية: Drug, medicine.medical_specialty, media_common.quotation_subject, IMPROVEMENT, AMERICAN-COLLEGE, Logistic regression, Antibodies, Monoclonal, Humanized, RECOMMENDATIONS, Therapy naive, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, DISEASE-ACTIVITY SCORE, CRITERIA, Humans, PREDICTORS, media_common, 030203 arthritis & rheumatology, business.industry, Proportional hazards model, Arthritis, Psoriatic, Interleukin-17, SPONDYLOARTHRITIS, EFFICACY, medicine.disease, RHEUMATOID-ARTHRITIS, 3. Good health, Europe, DEFINITION, Treatment Outcome, 3121 General medicine, internal medicine and other clinical medicine, Antirheumatic Agents, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Observational study, Secukinumab, business

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c44ffc681051948aa19acf5bc44d00b6Test
    https://pubmed.ncbi.nlm.nih.gov/33460531Test


    أضف إلى المفضلة
  9. 9
    Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry

    المؤلفون: Jakub Zavada, Lucie Nekvindová, Karel Pavelka, Zlatuše Křístková, Jiří Vencovský, Pavel Horák

    المصدر: Arthritis Research & Therapy
    Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)

    مصطلحات موضوعية: medicine.medical_specialty, Registry, lcsh:Diseases of the musculoskeletal system, Propensity score, medicine.medical_treatment, Logistic regression, Severity of Illness Index, Targeted therapy, Odds, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, Registries, Rheumatoid arthritis, 030203 arthritis & rheumatology, business.industry, Remission Induction, Odds ratio, medicine.disease, Rheumatology, Treatment Outcome, Antirheumatic Agents, Cohort, Propensity score matching, lcsh:RC925-935, business, Treat-to-target, Research Article

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b6a1fbe3418b1ede269bf9d0d23e3bTest
    https://pubmed.ncbi.nlm.nih.gov/33407803Test


    أضف إلى المفضلة
  10. 10
    Author response for 'Real‐world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO‐CLLEAR Study by the Czech CLL Study Group'

    المؤلفون: null Anna Panovská, null Lucie NĚmcová, null Lucie Nekvindová, null Martin Špaček, null Martin Šimkovič, null Tomáš Papajík, null Martin Brejcha, null Daniel Lysák, null Jana Zuchnická, null Jan Novák, null David Starostka, null Hynek Poul, null Filip Vrbacký, null Pavel Vodárek, null Renata Urbanová, null Karla Plevová, null Šárka Pospíšilová, null Stanislava Mašlejová, null Yvona Brychtová, null Eva KoriŤáková, null Lukáš Smolej, null Michael Doubek

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::923987ac4cdea213cf6b2db9b46e13d7Test
    https://doi.org/10.1002/hon.2744/v2/response1Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث